Suppr超能文献

造血干细胞移植患者血管通路装置的使用模式:一项国际调查结果

Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation: results of an international survey.

作者信息

Toro Juan J, Morales Manuel, Loberiza Fausto, Ochoa-Bayona Jose L, Freytes Cesar O

机构信息

Division of Hematology, Department of Medicine, Bone Marrow Transplant Unit, Audie L. Murphy Memorial Veterans Hospital, San Antonio, TX 78229-3900, USA.

出版信息

Support Care Cancer. 2007 Dec;15(12):1375-83. doi: 10.1007/s00520-007-0261-8. Epub 2007 May 8.

Abstract

INTRODUCTION

There is limited information regarding of use of vascular access devices (VAD) in patients undergoing hematopoietic stem cell transplantation (HSCT). The frequent use of VAD in HSCT and its potential to cause morbidity requires understanding of the general use of VAD in HSCT.

MATERIALS AND METHODS

A World Wide Web-based 19-item questionnaire was designed to determine the patterns of use of VAD in patients undergoing HSCT. The questionnaire was sent via electronic mail to the directors of HSCT programs throughout the world.

RESULTS

Of the 445 centers surveyed, 163 centers replied for a response rate of 37%. The most commonly used catheter for autologous peripheral blood stem cell (PBSC) harvest is the dual-lumen plasmapheresis/hemodialysis (62%). Of the institutions, 58% utilize the same catheter used for PBSC harvest to provide vascular access support during the transplant. Catheter-related blood stream infection (36%) and withdrawal occlusion (31%) were the most frequently encountered complications of VAD. Of the centers, 65% have established criteria for VAD removal when infection is suspected and 48% when occlusion is suspected.

DISCUSSION

Our study demonstrated that there are similarities in the utilization of VAD but also wide differences in the standard procedures for the insertion and care of VAD in the transplant setting. More comprehensive studies are needed to assess the use of central venous catheters in transplant recipients. Important areas for future research include the impact of VAD utilization on the quality of life of transplant recipients and the final consequences of VAD complications.

摘要

引言

关于造血干细胞移植(HSCT)患者使用血管通路装置(VAD)的信息有限。HSCT中VAD的频繁使用及其引发发病的可能性,需要了解VAD在HSCT中的一般使用情况。

材料与方法

设计了一份基于万维网的包含19个条目的问卷,以确定HSCT患者使用VAD的模式。该问卷通过电子邮件发送给全球HSCT项目的负责人。

结果

在接受调查的445个中心中,163个中心回复,回复率为37%。自体外周血干细胞(PBSC)采集最常用的导管是双腔血浆置换/血液透析导管(62%)。在这些机构中,58%使用用于PBSC采集的同一根导管在移植期间提供血管通路支持。导管相关血流感染(36%)和拔除时堵塞(31%)是VAD最常遇到的并发症。在这些中心中,65%已制定在怀疑感染时拔除VAD的标准,48%已制定在怀疑堵塞时拔除的标准。

讨论

我们的研究表明,VAD的使用存在相似之处,但在移植环境中VAD插入和护理的标准程序方面也存在很大差异。需要更全面的研究来评估移植受者中心静脉导管的使用情况。未来研究的重要领域包括VAD使用对移植受者生活质量的影响以及VAD并发症的最终后果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验